The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

While the CDSCO alert has named the brands for which they found spurious samples, the alert, however, does not name the ...

This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa Suit on a photo posted to X, The Tesla ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...

A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...

A cetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, may also increase ...

“This bipartisan legislation will promote generic drug competition and improve patient access to lower-cost medications,” said Senator Collins. “By reaffirming the so-called ‘skinny label’ pathway, ...

India’s drug regulator has found 41 drug samples tested in the central drug laboratories in November as 'Not of Standard ...